ZUM ZEITPUNKT DER ANGIOGRAPHIE NACH SUBARACHNOIDALBLUTUNGEN. = QUAND DOIT-ON PRATIQUER L'ANGIOGRAPHIE APRES UNE HEMORRAGIE SOUS-ARACHNOIDIENROOSEN K; BOCK WJ; WANDT H et al.1976; AKTUELLE CHIR.; DTSCH.; DA. 1976; VOL. 11; NO 3; PP. 141-146; ABS. ANGL.; BIBL. 21 REF.Article

Solid tumors. I: Germ cell tumors, breast cancerWANDT, H; SIEGERT, W.Bone marrow transplantation. Supplement (Basingstoke). 1993, Vol 12, Num 4, pp S79-S81, issn 0951-3078Conference Paper

Immunohistochemical evidence of estrogen and progesterone receptors in the female lower urinary tract and comparison with the vaginaWOLF, H; WANDT, H; JONAT, W et al.Gynecologic and obstetric investigation. 1991, Vol 32, Num 4, pp 227-231, issn 0378-7346Article

Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factorWANDT, H; SEIFERT, M; FALGE, C et al.Annals of hematology (Print). 1993, Vol 66, Num 5, pp 265-266, issn 0939-5555Article

Localized cerebral edema post high-dose chemotherapy and ABMT in a patient with germ cell tumorWANDT, H; BIRKMANN, J; SEIFERT, M et al.Bone marrow transplantation. Supplement (Basingstoke). 1992, Vol 10, Num 2, issn 0951-3078, p. 59Conference Paper

Consolidation treatment of high risk non-seminomatous germ cell tumor (NSGCT) with high-dose chemotherapy and ABMTWANDT, H; BIRKMANN, J; SEIFERT, M et al.Bone marrow transplantation. Supplement (Basingstoke). 1992, Vol 10, Num 2, issn 0951-3078, p. 58Conference Paper

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxinesGIESELER, F; GLASMACHER, A; KÄMPFE, D et al.Leukemia. 1996, Vol 10, Num 7, pp 1177-1180, issn 0887-6924Article

First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working PartyROSTI, G; DE GIORGI, U; WANDT, H et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 12, pp 1033-1037, issn 0268-3369, 5 p.Article

Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patientsBEHRE, G. F; SCHWARTZ, S; TREDER, W et al.Annals of hematology (Print). 1995, Vol 71, Num 6, pp 287-291, issn 0939-5555Article

Consolidation therapy with high-dose cytosine arabinoside : experiences of a prospective study in acute myeloid leukemiaKURRLE, E; EHNINGER, G; ÖHL, S et al.Haematology and blood transfusion. 1990, Vol 33, pp 254-260, issn 0171-7111Article

Mitoxantrone, cytosine arabinoside, and VP-16 in 36 patients with relapsed and refractory acute myeloid leukemiaLINK, H; FREUND, M; CALAVREZOS, A et al.Haematology and blood transfusion. 1990, Vol 33, pp 322-325, issn 0171-7111Article

Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12STREUBEL, B; SAUERLAND, C; BÜCHNER, T et al.British journal of haematology. 1998, Vol 100, Num 3, pp 521-533, issn 0007-1048Article

Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemiaEHNINGER, G; FACKLER-SCHWALBE, E; MITROU, P. S et al.Haematology and blood transfusion. 1990, Vol 33, pp 316-317, issn 0171-7111Article

A multicentre study on intensive induction and consolidation therapy in acute myelogeneous leukaemiaKURRLE, E; EHNINGER, G; WANDT, H et al.Blut. 1988, Vol 56, Num 5, pp 233-236, issn 0006-5242Article

Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22) : an additional deletion in 9q is an adverse prognostic factorSCHOCH, C; HAASE, D; LÖFFLER, H et al.Leukemia. 1996, Vol 10, Num 8, pp 1288-1295, issn 0887-6924Article

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxinesGIESELER, F; GLASMACHER, A; KÄMPFE, D et al.Leukemia. 1996, Vol 10, pp S46-S49, issn 0887-6924, SUP3Conference Paper

Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantationSCHMITZ, N; DREGER, P; ZANDER, A. R et al.Bone marrow transplantation (Basingstoke). 1995, Vol 15, Num 2, pp 261-266, issn 0268-3369Article

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCTHEBART, H; KLINGSPOR, L; ENGEL, C et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 7, pp 553-561, issn 0268-3369, 9 p.Article

High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission : retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)BENGALA, C; GUARNERI, V; DEMIRER, T et al.Bone marrow transplantation (Basingstoke). 2005, Vol 36, Num 1, pp 25-31, issn 0268-3369, 7 p.Article

Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experienceDE GIORGI, U; DEMIRER, T; WANDT, H et al.Annals of oncology. 2005, Vol 16, Num 1, pp 146-151, issn 0923-7534, 6 p.Article

The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma : results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)BUSKE, C; HOSTER, E; HESS, G et al.Leukemia. 2009, Vol 23, Num 1, pp 153-161, issn 0887-6924, 9 p.Article

Salvage Treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancerRICK, O; BOKEMEYER, C; HARTMANN, F et al.Journal of clinical oncology. 2001, Vol 19, Num 1, pp 81-88, issn 0732-183XArticle

Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantationDE WITTE, T; PIKKEMAAT, F; HAROUSSEAU, J et al.Leukemia. 2001, Vol 15, Num 12, pp 1878-1884, issn 0887-6924Conference Paper

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseARNOLD, R; MASSENKEIL, G; KOLB, H. J et al.Leukemia. 2002, Vol 16, Num 12, pp 2423-2428, issn 0887-6924, 6 p.Article

Safety and cost effectiveness of a 10 x 10⁹/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10⁹/L trigger : A prospective comparative trial in 105 patients with acute myeloid leukemiaWANDT, H; FRANK, M; HARMS, P et al.Blood. 1998, Vol 91, Num 10, pp 3601-3606, issn 0006-4971Article